Safety Issues Clinical Trials

19 recruiting

Safety Issues Trials at a Glance

19 actively recruiting trials for safety issues are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Lubin, Legnica, and Shanghai. Lead sponsors running safety issues studies include Regional Cardiology Center, The Copper Health Centre (MCZ),, First People's Hospital of Hangzhou, and Centre Hospitalier Universitaire de Liege.

Browse safety issues trials by phase

Treatments under study

About Safety Issues Clinical Trials

Looking for clinical trials for Safety Issues? There are currently 19 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Safety Issues trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Safety Issues clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting
Phase 1

Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects

Safety Issues
Shenyang Sunshine Pharmaceutical Co., LTD.26 enrolled1 locationNCT07058779
Recruiting
Phase 4

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Type II Diabetes MellitusEfficacy, SelfSafety Issues
Getz Pharma2,000 enrolled6 locationsNCT05164263
Recruiting
Not Applicable

BeSMART Secure Storage Counseling in the Inpatient Setting

Safety IssuesFirearm Injury
Vanderbilt University Medical Center400 enrolled2 locationsNCT06485141
Recruiting
Phase 1Phase 2

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Safety IssuesTolerabilityPharmacokinetics
Nanjing Immunophage Biotech Co., Ltd196 enrolled7 locationsNCT05142592
Recruiting

The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.

Efficacy, SelfSafety IssuesThromboembolic Disease+2 more
First People's Hospital of Hangzhou400 enrolled1 locationNCT04861506
Recruiting
Phase 1

Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients

Safety Issues
Taiwan Bio Therapeutics Inc.10 enrolled1 locationNCT05724576
Recruiting
Early Phase 1

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Safety IssuesTolerance
Kariya Pharmaceuticals88 enrolled1 locationNCT06189170
Recruiting
Not Applicable

Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever

Safety Issues
Shanghai Jiao Tong University School of Medicine200 enrolled1 locationNCT04270786
Recruiting

Pain Clinic Provides Public Health Safety

Chronic PainSafety IssuesSocial Functioning+3 more
Salem Anaesthesia Pain Clinic1,000 enrolled1 locationNCT06076512
Recruiting

Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B

Drug AdherencePatient SatisfactionEfficacy, Self+1 more
Taichung Veterans General Hospital60 enrolled1 locationNCT05583006
Recruiting

Lower Silesian Orbital Atherectomy Registry (LOAR)

Efficacy, SelfSafety Issues
Regional Cardiology Center, The Copper Health Centre (MCZ),500 enrolled2 locationsNCT06451146
Recruiting
Not Applicable

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Safety Issues
Cancer Institute and Hospital, Chinese Academy of Medical Sciences9 enrolled1 locationNCT06509490
Recruiting

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

Adverse Drug EventDrug UseDrug Side Effect+3 more
Universidade do Porto150 enrolled3 locationsNCT06498167
Recruiting
Not Applicable

Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

Safety IssuesBone Regeneration
Wishbone SA96 enrolled5 locationsNCT06383377
Recruiting
Phase 2

Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease?

EfficacySafety Issues
Centre Hospitalier Universitaire de Liege50 enrolled1 locationNCT06317818
Recruiting

Lower Silesia Culotte Bifurcation Registry (LSCBR).

Efficacy, SelfSafety Issues
Regional Cardiology Center, The Copper Health Centre (MCZ),400 enrolled2 locationsNCT06284057
Recruiting

Lower Silesia Sinus Reducer Registry

Efficacy, SelfSafety Issues
Regional Cardiology Center, The Copper Health Centre (MCZ),200 enrolled2 locationsNCT06288165
Recruiting

The Lower Silesia Shockwave Registry

Efficacy, SelfSafety Issues
Regional Cardiology Center, The Copper Health Centre (MCZ),400 enrolled2 locationsNCT05916898
Recruiting
Not Applicable

DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease

Efficacy, SelfSafety Issues
Peking Union Medical College Hospital200 enrolled1 locationNCT05517291